Ashton Thomas Private Wealth
EW icon

Ashton Thomas Private Wealth’s Edwards Lifesciences EW Stock Holding History

Ashton Thomas Private Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$448K Buy
5,195
+483
+10% +$42.9K 0.01% 823
2026
Q2 		$426K Sell
4,712
-1,438
-23% -$120K 0.01% 841
2026
Q1 		$493K Buy
6,150
+3,243
+112% +$267K 0.01% 729
2025
Q4 		$248K Buy
+2,907
New +$239K 0.01% 889
2024
Q3 		– Sell
-2,448
Closed -$226K – 1000
2024
Q2 		$226K Buy
2,448
+40
+2% +$3.54K 0.01% 541
2024
Q1 		$230K Sell
2,408
-758
-24% -$63.7K 0.01% 552
2023
Q4 		$241K Sell
3,166
-2,056
-39% -$143K 0.02% 529
2023
Q3 		$362K Buy
5,222
+2,470
+90% +$198K 0.03% 452
2023
Q2 		$260K Sell
2,752
-97
-3% -$8.43K 0.02% 509
2023
Q1 		$236K Buy
2,849
+163
+6% +$12.8K 0.02% 455
2022
Q4 		$200K Sell
2,686
-309
-10% -$23.8K 0.02% 457
2022
Q3 		$247K Buy
2,995
+6
+0.2% +$577 0.03% 414
2022
Q2 		$284K Sell
2,989
-4,653
-61% -$482K 0.03% 384
2022
Q1 		$900K Sell
7,642
-219
-3% -$24.6K 0.08% 264
2021
Q4 		$1.02M Buy
7,861
+591
+8% +$68.9K 0.1% 232
2021
Q3 		$823K Buy
7,270
+673
+10% +$76.8K 0.12% 191
2021
Q2 		$683K Sell
6,597
-2,866
-30% -$270K 0.1% 216
2021
Q1 		$791K Sell
9,463
-936
-9% -$79.1K 0.13% 180
2020
Q4 		$949K Buy
10,399
+2,240
+27% +$186K 0.18% 155
2020
Q3 		$651K Buy
8,159
+4,297
+111% +$335K 0.16% 152
2020
Q2 		$267K Buy
+3,862
New +$274K 0.08% 200

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

Ashton Thomas Private Wealth's EW Position: Q3 2026 in Review

Ashton Thomas Private Wealth increased its Edwards Lifesciences (EW) stake by 10% in Q3 2026, buying an estimated $42.9K and bringing the position to 5,195 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #823.

Ashton Thomas Private Wealth first reported a position in EW in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.02M in Q4 2021. 851 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Ashton Thomas Private Wealth held 5,195 shares of Edwards Lifesciences worth $448K as of Q3 2026.
  • Ashton Thomas Private Wealth bought 483 Edwards Lifesciences shares in Q3 2026, an estimated $42.9K.
  • Edwards Lifesciences made up 0.01% of Ashton Thomas Private Wealth's portfolio in Q3 2026, its #823 holding.
  • Ashton Thomas Private Wealth first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 21 quarters since.
  • Ashton Thomas Private Wealth's Edwards Lifesciences position peaked at $1.02M in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.